Novonesis issues EUR 1.7 billion senior unsecured notes

On March 12, 2026, Novonesis, through Novozymes A/S, successfully priced and closed an aggregate principal amount of EUR 1.7 billion senior unsecured notes (the "Notes"). The issuance was completed under the newly established EUR 4 billion Euro Medium Term Note (EMTN) Programme, dated March 10, 2026.

The Notes will be issued on March 19, 2026, and listed on the Luxembourg Stock Exchange. This inaugural issuance consists of three tranches with maturities ranging from 4 to 11 years and fixed interest rates ranging from 3.25% to 4.00%.

Novonesis has been rated A- (stable outlook) by Standard & Poor's (S&P).

The net proceeds from the transaction will be used to refinance existing debt and for general corporate purposes.

For further details about the EMTN Programme and this issuance, please visit our website.

Contact information

Investor Relations                                                      
Tobias Bjorklund                             +45 3077 8682                                [email protected]
Anders Enevoldsen                         +45 5350 1453                                [email protected]

Treasury                                         
Frants Bisgaard Pedersen              +45 3077 0342                                [email protected]

Media Relations                            
Jens Gamborg                                 +45 3077 7182                                 [email protected]

Attachment

• 2026_EMTN_Programme

You May Also Be Interested In

• Sonatype Research Labs Marks 15 Years of Software Supply Chain Intelligence
• Sigenergy Unveils SigenMate 2700 Ultra: a Future-Ready AI-Powered Plug & Play Home Energy System
• Form 8.5 (EPT/RI) - Kore Potash Plc